(Total Views: 293)
Posted On: 06/29/2017 11:56:35 PM
Post# of 72446
Re: starboardtack #35431
From your buddy Phteven C,
Quote:
All this discussion of trial costs is pointless as the overwhelming likelihood is we will be partnering or selling at least one of our assets in the next 3-12 months. Indulging it is foolishness as it won't matter soon.
But just to indulge it a little...who cares if the trial costs $10M or $15M or $30M or $45M? The resulting dilution, assuming successful drugs, might affect whether we make it to $50 instead of $60 or $70 or $100. It doesn't impact whether one should be in this stock now. It's not going to impact whether we make it to $10 or even $20. The first 10-bagger is all on the science.
(1)
(0)
